Sentinel Lymph-Node Biopsy in Early-Stage Cervical Cancer: The 4-Year Follow-Up Results of the Senticol 2 Trial

Sentinel Lymph-Node Biopsy in Early-Stage Cervical Cancer: The 4-Year Follow-Up Results of the Senticol 2 Trial

IntroductionSenticol 2 is a randomized multicenter trial in the treatment of early-stage cervical cancer patients. The aim of the Senticol 2 study was to compare the effect of sentinel-lymph-node biopsy (SLNB) to that of SLNB + pelvic lymphadenectomy (PLND), and to determine the postoperative lympha...

Full description

Bibliographic Details
Main Authors: Guillaume Favre, Benedetta Guani, Vincent Balaya, Laurent Magaud, Fabrice Lecuru, Patrice Mathevet
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Oncology
Subjects:
cervical cancer
sentinel lymph node
lymphadenectomy
survival
lymph node biopsy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2020.621518/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2020.621518/full

Similar Items